181 related articles for article (PubMed ID: 8960058)
1. A fragment consisting of the first 204 amino-terminal amino acids of human arylamine N-acetyltransferase one (NAT1) and the first transacetylation step of catalysis.
Sinclair J; Sim E
Biochem Pharmacol; 1997 Jan; 53(1):11-6. PubMed ID: 8960058
[TBL] [Abstract][Full Text] [Related]
2. Metabolic activation and deactivation of arylamine carcinogens by recombinant human NAT1 and polymorphic NAT2 acetyltransferases.
Hein DW; Doll MA; Rustan TD; Gray K; Feng Y; Ferguson RJ; Grant DM
Carcinogenesis; 1993 Aug; 14(8):1633-8. PubMed ID: 8353847
[TBL] [Abstract][Full Text] [Related]
3. Redox regulation of the human xenobiotic metabolizing enzyme arylamine N-acetyltransferase 1 (NAT1). Reversible inactivation by hydrogen peroxide.
Atmane N; Dairou J; Paul A; Dupret JM; Rodrigues-Lima F
J Biol Chem; 2003 Sep; 278(37):35086-92. PubMed ID: 12832400
[TBL] [Abstract][Full Text] [Related]
4. Insight into cofactor recognition in arylamine N-acetyltransferase enzymes: structure of Mesorhizobium loti arylamine N-acetyltransferase in complex with coenzyme A.
Xu X; Li de la Sierra-Gallay I; Kubiak X; Duval R; Chaffotte AF; Dupret JM; Haouz A; Rodrigues-Lima F
Acta Crystallogr D Biol Crystallogr; 2015 Feb; 71(Pt 2):266-73. PubMed ID: 25664736
[TBL] [Abstract][Full Text] [Related]
5. Human arylamine N-acetyltransferase 1: in vitro and intracellular inactivation by nitrosoarene metabolites of toxic and carcinogenic arylamines.
Liu L; Wagner CR; Hanna PE
Chem Res Toxicol; 2008 Oct; 21(10):2005-16. PubMed ID: 18759501
[TBL] [Abstract][Full Text] [Related]
6. Modulation of Human Arylamine
Butcher NJ; Burow R; Minchin RF
Mol Pharmacol; 2020 Aug; 98(2):88-95. PubMed ID: 32487734
[TBL] [Abstract][Full Text] [Related]
7. Acetylation of p-aminobenzoylglutamate, a folic acid catabolite, by recombinant human arylamine N-acetyltransferase and U937 cells.
Minchin RF
Biochem J; 1995 Apr; 307 ( Pt 1)(Pt 1):1-3. PubMed ID: 7717963
[TBL] [Abstract][Full Text] [Related]
8. Monomorphic and polymorphic human arylamine N-acetyltransferases: a comparison of liver isozymes and expressed products of two cloned genes.
Grant DM; Blum M; Beer M; Meyer UA
Mol Pharmacol; 1991 Feb; 39(2):184-91. PubMed ID: 1996083
[TBL] [Abstract][Full Text] [Related]
9. Biochemical characterization of recombinant serotonin N-acetyltransferase.
Zhan-Poe X; Craft CM
J Pineal Res; 1999 Aug; 27(1):49-58. PubMed ID: 10451024
[TBL] [Abstract][Full Text] [Related]
10. From arylamine N-acetyltransferase to folate-dependent acetyl CoA hydrolase: impact of folic acid on the activity of (HUMAN)NAT1 and its homologue (MOUSE)NAT2.
Laurieri N; Dairou J; Egleton JE; Stanley LA; Russell AJ; Dupret JM; Sim E; Rodrigues-Lima F
PLoS One; 2014; 9(5):e96370. PubMed ID: 24823794
[TBL] [Abstract][Full Text] [Related]
11. Arylamine N-acetyltransferases: structural and functional implications of polymorphisms.
Sim E; Lack N; Wang CJ; Long H; Westwood I; Fullam E; Kawamura A
Toxicology; 2008 Dec; 254(3):170-83. PubMed ID: 18852012
[TBL] [Abstract][Full Text] [Related]
12. Structure-function studies of human arylamine N-acetyltransferases NAT1 and NAT2. Functional analysis of recombinant NAT1/NAT2 chimeras expressed in Escherichia coli.
Dupret JM; Goodfellow GH; Janezic SA; Grant DM
J Biol Chem; 1994 Oct; 269(43):26830-5. PubMed ID: 7929420
[TBL] [Abstract][Full Text] [Related]
13. Polymorphic expression of acetyl coenzyme A-dependent arylamine N-acetyltransferase and acetyl coenzyme A-dependent O-acetyltransferase-mediated activation of N-hydroxyarylamines by human bladder cytosol.
Kirlin WG; Trinidad A; Yerokun T; Ogolla F; Ferguson RJ; Andrews AF; Brady PK; Hein DW
Cancer Res; 1989 May; 49(9):2448-54. PubMed ID: 2784998
[TBL] [Abstract][Full Text] [Related]
14. Arylamine N-acetyltransferases: characterization of the substrate specificities and molecular interactions of environmental arylamines with human NAT1 and NAT2.
Liu L; Von Vett A; Zhang N; Walters KJ; Wagner CR; Hanna PE
Chem Res Toxicol; 2007 Sep; 20(9):1300-8. PubMed ID: 17672512
[TBL] [Abstract][Full Text] [Related]
15. Human N-acetylation of benzidine: role of NAT1 and NAT2.
Zenser TV; Lakshmi VM; Rustan TD; Doll MA; Deitz AC; Davis BB; Hein DW
Cancer Res; 1996 Sep; 56(17):3941-7. PubMed ID: 8752161
[TBL] [Abstract][Full Text] [Related]
16. The role of lysine(100) in the binding of acetylcoenzyme A to human arylamine N-acetyltransferase 1: implications for other acetyltransferases.
Minchin RF; Butcher NJ
Biochem Pharmacol; 2015 Apr; 94(3):195-202. PubMed ID: 25660616
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the active site, substrate specificity and kinetic properties of acetyl-CoA:arylamine N-acetyltransferase from pigeon liver.
Andres HH; Kolb HJ; Schreiber RJ; Weiss L
Biochim Biophys Acta; 1983 Aug; 746(3):193-201. PubMed ID: 6882770
[TBL] [Abstract][Full Text] [Related]
18. Identification of amino acids imparting acceptor substrate selectivity to human arylamine acetyltransferases NAT1 and NAT2.
Goodfellow GH; Dupret JM; Grant DM
Biochem J; 2000 May; 348 Pt 1(Pt 1):159-66. PubMed ID: 10794727
[TBL] [Abstract][Full Text] [Related]
19. Human
Hein DW; Doll MA; Habil MR
Front Pharmacol; 2022; 13():821133. PubMed ID: 35281898
[TBL] [Abstract][Full Text] [Related]
20. Isoform-selective inactivation of human arylamine N-acetyltransferases by reactive metabolites of carcinogenic arylamines.
Liu L; Wagner CR; Hanna PE
Chem Res Toxicol; 2009 Dec; 22(12):1962-74. PubMed ID: 19842618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]